Expert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers
In this podcast episode, listen to Kathleen Moore, MD, MS, and Nicoletta Colombo, MD, PhD, discuss key updates and new clinical trial data for gynecologic cancers presented at the 2023 ASCO Annual Meeting, including final overall survival data from KEYNOTE-826; a study from the Canadian Cancer Trials Network on radical vs simple hysterectomy in locally advanced, recurrent cervical cancers; and new data for novel combinations of immunotherapy plus PARP inhibitors in ovarian and endometrial cancer.